Bradley Foster & Sargent Inc Crispr Therapeutics Ag Put Options Transaction History
Bradley Foster & Sargent Inc
- $5.77 Billion
- Q4 2024
Put Options
0 transactions
| Quarter | Operation | Price Per put | puts change | puts Held | SEC Form |
|---|
Others Institutions Holding CRSP
# of Institutions
488Shares Held
59MCall Options Held
1.09MPut Options Held
1.9M-
Cathie Wood Ark Investment Management LLC | St. Petersburg, Fl8.97MShares$356 Million3.09% of portfolio
-
Capital International Investors Los Angeles, CA7.93MShares$315 Million0.07% of portfolio
-
State Street Corp Boston, MA2.99MShares$119 Million0.01% of portfolio
-
Nikko Asset Management Americas, Inc.2.97MShares$118 Million1.61% of portfolio
-
Black Rock Inc. New York, NY2.78MShares$110 Million0.0% of portfolio
About CRISPR Therapeutics AG
- Ticker CRSP
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 78,009,296
- Market Cap $3.1B
- Description
- CRISPR Therapeutics AG, a gene editing company, focuses on developing gene-based medicines for serious diseases using its proprietary Clustered Regularly Interspaced Short Palindromic Repeats (CRISPR)/CRISPR-associated protein 9 (Cas9) platform. Its CRISPR/Cas9 is a gene editing technology that allows for precise directed changes to genomic DNA....